Cargando…
A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis
RATIONALE: Ustekinumab is a biological agent that inhibits interleukin 12 and 23 and has been approved for the treatment of moderate and severe plaque psoriasis. There have been case reports that raise concerns about its oncogenic potential. We are the first authors to report a case of Hodgkin lymph...
Autores principales: | Charakopoulos, Emmanouil, Spyrou, Ioannis, Viniou, Nora-Athina, Giannakopoulou, Nefeli, Hatzidavid, Sevastianos, Diamantopoulos, Panagiotis Theodorou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249998/ https://www.ncbi.nlm.nih.gov/pubmed/32481271 http://dx.doi.org/10.1097/MD.0000000000020048 |
Ejemplares similares
-
Isolated skeletal muscle recurrence of an originally nodal diffuse large B cell lymphoma: A case report and review of the literature
por: Spetsieris, Nikolaos, et al.
Publicado: (2018) -
Bacillus Cereus in Hematological Malignancies
por: Markouli, Mariam, et al.
Publicado: (2022) -
JAK2V617F positive polycythemia vera with paroxysmal nocturnal hemoglobinuria and visceral thromboses: a case report and review of the literature
por: Chatzidavid, Sevastianos, et al.
Publicado: (2021) -
An unusual case report of unilateral parotid gland sarcoidosis with spontaneous remission
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2019) -
PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome
por: Kontandreopoulou, Christina-Nefeli, et al.
Publicado: (2021)